The purpose of this study is to determine if association of methotrexate with adalimumab leads to decrease immunogenicity beside adalimumab alone in Ankylosing Spondylitis.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01895764?cond=%22Arthritis%22&lup_s=01/29/2014&lup_d=30
